JP2019516406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019516406A5 JP2019516406A5 JP2019512943A JP2019512943A JP2019516406A5 JP 2019516406 A5 JP2019516406 A5 JP 2019516406A5 JP 2019512943 A JP2019512943 A JP 2019512943A JP 2019512943 A JP2019512943 A JP 2019512943A JP 2019516406 A5 JP2019516406 A5 JP 2019516406A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarkers
- expression
- classifier
- sample
- biomarker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662337645P | 2016-05-17 | 2016-05-17 | |
| US62/337,645 | 2016-05-17 | ||
| US201662379402P | 2016-08-25 | 2016-08-25 | |
| US62/379,402 | 2016-08-25 | ||
| US201662396587P | 2016-09-19 | 2016-09-19 | |
| US62/396,587 | 2016-09-19 | ||
| US201662420836P | 2016-11-11 | 2016-11-11 | |
| US62/420,836 | 2016-11-11 | ||
| US201662425717P | 2016-11-23 | 2016-11-23 | |
| US62/425,717 | 2016-11-23 | ||
| PCT/US2017/033107 WO2017201164A1 (en) | 2016-05-17 | 2017-05-17 | Methods for subtyping of lung squamous cell carcinoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019516406A JP2019516406A (ja) | 2019-06-20 |
| JP2019516406A5 true JP2019516406A5 (enExample) | 2020-06-25 |
| JP7241352B2 JP7241352B2 (ja) | 2023-03-17 |
Family
ID=60325556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512943A Active JP7241352B2 (ja) | 2016-05-17 | 2017-05-17 | 肺扁平上皮癌のサブタイピングのための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11041214B2 (enExample) |
| EP (1) | EP3458611B1 (enExample) |
| JP (1) | JP7241352B2 (enExample) |
| CN (1) | CN109863251B (enExample) |
| CA (1) | CA3024744A1 (enExample) |
| WO (1) | WO2017201164A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3149209B1 (en) | 2014-05-30 | 2021-02-17 | Genecentric Therapeutics, Inc. | Methods for typing of lung cancer |
| CA3024744A1 (en) | 2016-05-17 | 2017-11-23 | Genecentric Therapeutics, Inc. | Methods for subtyping of lung squamous cell carcinoma |
| US10934595B2 (en) | 2016-05-17 | 2021-03-02 | Genecentric Therapeutics, Inc. | Methods for subtyping of lung adenocarcinoma |
| US12195805B2 (en) | 2018-02-13 | 2025-01-14 | Genecentric Therapeutics, Inc. | Methods for subtyping of bladder cancer |
| WO2020076897A1 (en) | 2018-10-09 | 2020-04-16 | Genecentric Therapeutics, Inc. | Detecting cancer cell of origin |
| DE102018125324A1 (de) * | 2018-10-12 | 2020-04-16 | Universität Rostock | Verfahren zur Vorhersage einer Antwort auf die Therapie von Krankheiten |
| WO2021041726A1 (en) * | 2019-08-27 | 2021-03-04 | Exact Sciences Development Company, Llc | Characterizing methylated dna, rna, and proteins in subjects suspected of having lung neoplasia |
| CN111369501B (zh) * | 2020-02-24 | 2022-04-01 | 武汉大学 | 一种基于视觉特征识别口腔鳞状细胞癌的深度学习方法 |
| CN111653312B (zh) * | 2020-05-28 | 2021-04-16 | 上海宝藤生物医药科技股份有限公司 | 一种利用基因组数据探究疾病亚型亲缘性的方法 |
| CN111755073B (zh) * | 2020-05-31 | 2022-11-15 | 复旦大学 | 基于转录组的pd-1疗法治疗效果预测系统 |
| CN112433054A (zh) * | 2020-11-20 | 2021-03-02 | 四川大学华西医院 | C9蛋白检测试剂在制备肺癌筛查试剂盒中的用途 |
| WO2022226391A1 (en) * | 2021-04-23 | 2022-10-27 | The Trustees Of Columbia University In The City Of New York | Methods for detecting squamous cancer |
| CN115308418B (zh) * | 2022-07-07 | 2024-11-08 | 翁良 | 一种生物标志物及其在肺鳞癌诊断中的应用 |
| CN116129998B (zh) * | 2023-01-19 | 2024-06-11 | 中国医学科学院肿瘤医院 | 一种食管鳞状细胞癌数据的处理方法及其系统 |
| CN115982644B (zh) * | 2023-01-19 | 2024-04-30 | 中国医学科学院肿瘤医院 | 一种食管鳞状细胞癌分类模型构建与数据处理方法 |
| CN116287253B (zh) * | 2023-02-22 | 2024-06-28 | 武汉科技大学 | 一种肺癌分子标志物及其应用 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| CA2118806A1 (en) | 1991-09-18 | 1993-04-01 | William J. Dower | Method of synthesizing diverse collections of oligomers |
| AU675054B2 (en) | 1991-11-22 | 1997-01-23 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| DE69829402T2 (de) | 1997-10-31 | 2006-04-13 | Affymetrix, Inc. (a Delaware Corp.), Santa Clara | Expressionsprofile in adulten und fötalen organen |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6670321B1 (en) | 1998-12-30 | 2003-12-30 | The Children's Medical Center Corporation | Prevention and treatment for retinal ischemia and edema |
| AU2002226912A1 (en) | 2000-11-16 | 2002-05-27 | Cedars-Sinai Medical Center | Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease |
| US7473767B2 (en) | 2001-07-03 | 2009-01-06 | The Institute For Systems Biology | Methods for detection and quantification of analytes in complex mixtures |
| AU2002343443A1 (en) | 2001-09-28 | 2003-04-14 | Whitehead Institute For Biomedical Research | Classification of lung carcinomas using gene expression analysis |
| US20060024692A1 (en) | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
| TW200413725A (en) | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
| JP2007006792A (ja) | 2005-06-30 | 2007-01-18 | Hitachi Software Eng Co Ltd | 肺腺癌の胸膜浸潤を判別するための遺伝子セット |
| WO2008151110A2 (en) | 2007-06-01 | 2008-12-11 | The University Of North Carolina At Chapel Hill | Molecular diagnosis and typing of lung cancer variants |
| WO2009046738A1 (en) * | 2007-10-09 | 2009-04-16 | Curevac Gmbh | Composition for treating lung cancer, particularly of non-small lung cancers (nsclc) |
| CA2726531A1 (en) | 2008-06-05 | 2009-12-10 | University Health Network | Compositions and methods for classifying lung cancer and prognosing lung cancer survival |
| CN101509035A (zh) | 2008-09-05 | 2009-08-19 | 中国人民解放军总医院 | 肺癌分型的基因序列及其应用 |
| WO2013172926A1 (en) * | 2012-05-14 | 2013-11-21 | Yale University | Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer |
| WO2013192089A1 (en) * | 2012-06-18 | 2013-12-27 | The University Of North Carolina At Chapel Hill | Methods for head and neck cancer prognosis |
| EP2806274A1 (en) * | 2013-05-24 | 2014-11-26 | AIT Austrian Institute of Technology GmbH | Lung cancer diagnostic method and means |
| US20150057335A1 (en) | 2013-08-20 | 2015-02-26 | National Cancer Center | Novel fusion genes identified in lung cancer |
| EP3603748A1 (en) * | 2014-05-13 | 2020-02-05 | MedImmune Limited | Anti-b7-h1 and anti-ctla-4 antibodies for treating non-small cell lung cancer |
| US9885721B2 (en) | 2014-05-29 | 2018-02-06 | Spring Bioscience Corporation | PD-L1 antibodies and uses thereof |
| EP3149209B1 (en) | 2014-05-30 | 2021-02-17 | Genecentric Therapeutics, Inc. | Methods for typing of lung cancer |
| MX389663B (es) * | 2014-10-14 | 2025-03-20 | Novartis Ag | Moleculas de anticuerpo que se unen a pd-l1 y usos de las mismas. |
| CN107849613A (zh) | 2015-04-14 | 2018-03-27 | 基因中心治疗公司 | 用于肺癌分型的方法 |
| US10934595B2 (en) | 2016-05-17 | 2021-03-02 | Genecentric Therapeutics, Inc. | Methods for subtyping of lung adenocarcinoma |
| CA3024744A1 (en) | 2016-05-17 | 2017-11-23 | Genecentric Therapeutics, Inc. | Methods for subtyping of lung squamous cell carcinoma |
| WO2019018764A1 (en) | 2017-07-21 | 2019-01-24 | Genecentric Therapeutics, Inc. | METHODS OF DETERMINING RESPONSE TO PARP INHIBITORS |
-
2017
- 2017-05-17 CA CA3024744A patent/CA3024744A1/en active Pending
- 2017-05-17 EP EP17800090.7A patent/EP3458611B1/en active Active
- 2017-05-17 WO PCT/US2017/033107 patent/WO2017201164A1/en not_active Ceased
- 2017-05-17 JP JP2019512943A patent/JP7241352B2/ja active Active
- 2017-05-17 CN CN201780044228.2A patent/CN109863251B/zh active Active
- 2017-05-17 US US16/302,170 patent/US11041214B2/en active Active
-
2021
- 2021-05-18 US US17/323,429 patent/US12139765B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019516406A5 (enExample) | ||
| JP2019516407A5 (enExample) | ||
| EP2715348B1 (en) | Molecular diagnostic test for cancer | |
| CN102149827B (zh) | MiR-26家族作为肝细胞癌和对治疗的应答性的预测性标志物的用途 | |
| Bianchini et al. | Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa | |
| EP3179393B1 (en) | Gene expression profile algorithm and test for determining prognosis of prostate cancer | |
| EP2925885B1 (en) | Molecular diagnostic test for cancer | |
| ES2611000T3 (es) | Método para usar la expresión génica para determinar el pronóstico de cáncer de próstata | |
| JP7241352B2 (ja) | 肺扁平上皮癌のサブタイピングのための方法 | |
| JP6144695B2 (ja) | タキサン療法を用いて乳癌を処置する方法 | |
| CA2859663A1 (en) | Identification of multigene biomarkers | |
| CN103547682B (zh) | 肝细胞癌的基因标签 | |
| AU2012261820A1 (en) | Molecular diagnostic test for cancer | |
| JP2016505247A5 (enExample) | ||
| WO2016014705A1 (en) | Characterization of melanoma using a molecular signature | |
| US20250137066A1 (en) | Compostions and methods for diagnosing lung cancers using gene expression profiles | |
| WO2017136508A1 (en) | Dissociation of human tumor to single cell suspension followed by biological analysis | |
| US9410205B2 (en) | Methods for predicting survival in metastatic melanoma patients | |
| WO2015179777A2 (en) | Gene expression profiles associated with sub-clinical kidney transplant rejection | |
| EP1613767B1 (en) | Method of defining the differentiation grade of tumor | |
| AU2021221905B2 (en) | Gene expression profiles associated with sub-clinical kidney transplant rejection | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| CN110129444A (zh) | 一种检测放射性损伤的试剂及其应用 | |
| CN114032308A (zh) | Fam83a、kpna2、krt6a和ldha联合作为肺腺癌生物标志物的用途 | |
| CN114901836A (zh) | 肝移植的临床和分子预后标志物 |